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In the previous issue of *Critical Care*, Vaschetto and colleagues \[[@B1]\] sought to determine whether and by which mechanism(s) the activation of poly(ADP-ribose) polymerase (PARP) contributes to the acute kidney injury (AKI) induced by injurious mechanical ventilation (MV). The authors used a double-hit rat model of acute lung injury comprising lipopolysaccharide-induced lung inflammation and MV with either very high tidal volume (19 mL/kg, zero positive end-expiratory pressure \[PEEP\]) or low tidal volume (6 mL/kg, PEEP 5 cm H~2~O). To address the role of peroxynitrite and PARP in mediating MV-induce kidney injury, the rats challenged with high-tidal-volume MV were pre-treated with peroxynitrite decomposition catalyst (WW85) or a PARP inhibitor (PJ-34). The authors\' key findings were that both strategies preserved renal perfusion, attenuated renal endothelial dysfunction, and ameliorated intrarenal inflammation.

The issue of AKI due to MV is an old but still virtually not understood phenomenon and is, however, of major concern \[[@B2]\]. Traditionally, deteriorations in systemic and renal hemodynamics and gas exchange associated with MV have been implicated in this process \[[@B3]\]. There is an emerging concept that MV exerts a broad spectrum of harmful biological responses with the capacity to affect functions of remote organs \[[@B4],[@B5]\], including the kidney \[[@B6],[@B7]\]. An altered inflammatory net work, oxidative stress, and apoptosis have been considered the central hubs of this organ crosstalk in response to MV \[[@B8],[@B9]\].

Generation of reactive oxygen and nitrogen species has been demonstrated during various acute conditions \[[@B10]\]. One of the most important secondary injuries resulting from oxidative stress is oxidative DNA damage leading to overactivation of PARP. Its activation results in depletion of NAD^+^and ATP and consequently in cell death and organ dysfunction \[[@B10]\]. Not only compromised cellular energy metabolism but also PARP-mediated upregulation of numerous pro-inflammatory pathways makes the pharmacological modulation of PARP activity a suitable target to prevent the tissue injury \[[@B10]-[@B12]\]. Therefore, the hypothesis of the peroxynitrite-PARP-dependent path way as an important pathogenic contributor to ventilator-induced kidney injury \[[@B8]\] is tempting. Indeed, evidence derived from several studies suggests that PARP is activated in both ventilator-induced lung injury (VILI) \[[@B13]\] and AKI \[[@B14]\]. In addition to direct PARP inhibition, neutralization of cytotoxic effects of molecules such as iNOS (inducible nitric-oxide synthase)-derived nitric oxide might constitute an interesting tool to protect the kidney \[[@B15],[@B16]\].

The study by Vaschetto and colleagues \[[@B1]\] is a complementary experimental study of the research group that has previously demonstrated impressive beneficial effects of PARP inhibition on VILI, systemic inflammatory response, and kidney function in a very similar experimental setting \[[@B17]\]. Their present study \[[@B1]\] extends these findings by providing further insights into the mechanisms by which PARP inhibition provides kidney protection. Peroxinitrite-PARS (poly \[ADP-ribose\] synthetase) inhibition preserved renal microvascular stability and attenuated renal tissue leukocyte infiltration. These findings are of particular relevance to the kidney as recent research underscored the importance of renal microcirculation and intrarenal inflammation as possibly causative features in AKI \[[@B18],[@B19]\].

Although we have learned a great deal from the study by Vaschetto and colleagues \[[@B1]\], some critical aspects of the study need to be addressed. To induce significant VILI and remote organ dysfunction, the authors had to use highly injurious ventilatory settings associated with profound hypotension and this use would be considered *non lege artis*in clinical practice. Moreover, no standard therapeutic measures such as fluid resuscitation or vasoactive drugs to maintain renal blood flow were administered. Finally, they tested the role of the peroxynitrite-PARP-dependent pathway in animals challenged with high tidal volume only, thus leaving its role in clinically more relevant scenarios open to speculation. In fact, in their previous study, the authors observed no significant differences between animals ventilated with low tidal volume (6 mL/kg, PEEP 5 cm H~2~O) and treated or not treated with PARP inhibition \[[@B17]\]. Therefore, it is tempting to speculate that lung-protective ventilation might produce only subtle inflammatory insults insufficient to trigger PARP overactivation in remote organs. Furthermore, the short-term nature and pre-treatment design of the study as well as the lack of direct measurements of time-related changes in tissue PARP activity and 3-nitrotyrosine (an index of peroxynitrite) make the applicability of the results to the clinical scenario problematic. Finally, the double-hit model does not allow investigators to dissect whether the major stimulus for peroxynitrite-PARP-derived toxicity is endotoxin or injurious ventilation or both.

Where do we go from here? Mitigation of VILI-induced lung and remote organ injury by interfering with the pathobiological pathways involved is a promising concept, albeit still far from the clinical arena. Though leaving important aspects open to speculation, the studies by Vaschetto and colleagues provide interesting mechanistic insights into the increasingly challenging aspects of the complex inflammatory network implicated in bidirectional organ crosstalk and should stimulate further research in this direction.
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